GLP-1 (glucagon-like peptide-1) agonists and related medications, originally developed for the treatment of type 2 diabetes, have gained significant attention for their efficacy in promoting weight loss. Medications such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro,… Read More »